Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 6 of 6 for “"Intravesical immunotherapy"”.
-
INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) AND INTERFERON ALPHA-2B IN THE TREATMENT OF SUPERFICIAL BLADDER CANCER - A CLINICAL AND IMMUNOLOGICAL STUDY
… with the trial medication. The host response to intravesical immunotherapy was correlated with the clinical response by urinary cytokine analysis during therapy. Analysis was based on intention-to-treat
-
Effect of Systemic Versus Localized Bacillus Calmette-Guérin Immunotherapy on Bladder Cancer Progression: Novel Role for Trained Immunity
… invasive bladder cancer (NMIBC) involves intravesical immunotherapy with Bacillus Calmette Guérin (BCG). Unfortunately, most patients do not respond fully to this therapy, and our understanding of the immunotherapeutic effect of BCG is incomplete. The tumor immune microenvironment (TiME) …
-
Investigating the role of systemic innate immune reprogramming in the mode of action of Bacillus Calmette–guérin therapy for non-muscle invasive bladder cancer
… surgical resection of tumours, followed by intravesical immunotherapy in higher risk cases. The immunotherapeutic agent used is the tuberculosis vaccine, Bacillus Calmette-Guérin (BCG). Despite being the gold standard for over three decades, BCG’s therapeutic mechanism remains incompletely …
-
Untersuchung der lokalen und systemischen Immunantwort nach intravesikaler BCG-Behandlung des oberflächlichen Harnblasenkarzinoms
Einleitung: Ziel der vorliegenden Studie war die Untersuchung der lokalen und systemischen Immunantwort nach intravesikaler BCG-Behandlung des oberflächlichen Harnblasenkarzinoms. <br>Material und Methoden: Insgesamt 37 Patienten mit oberflächlichen Harnblasenkarzinomen der Stadien Ta bis T1b …
-
Chitosan Decontamination with Non-Thermal Nitrogen Plasma to Enable Internal Use
<p>Chitosan (CS) is a ubiquitous biopolymer and is recognized as a promising biomedical material. Potential medical applications for chitosan are extensive and many have shown impressive results. However, chitosan is clinically only used as a topical hemostatic agent due to an inability to …
-
Συμβολή στην ανεύρεση του καλύτερου δοσολογικού σχήματος ιντερφερόνης (40MUI, 60MUI, 80MUI) για την προφύλαξη από τις υποτροπές των επιφανειακών όγκων της ουροδόχου κύστης, μέσης κακοήθειας
… on 89 patients (20 controls and 69 patients with intravesical instillations of Interferon a-26) with a mean age of 61, 62 (±9,63) years from which 65 patients (73,3%) were shown to have a single tumor whereas 24 patients (26,7%) were shown to have multiple tumors, (multifocal disease). The …